Colonoscopy screening compliance and outcomes in patients with lynch syndrome

Colorectal Disease

Volumn 17, Issue 1, 2015, Pages 38-46

  Newton, K ^a   Green, K ^b   Lalloo, F ^b   Evans, D G ^b   Hill, J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Colorectal cancer; HNPCC; Lynch syndrome; Screening; Surveillance

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COMPUTED TOMOGRAPHIC COLONOGRAPHY; FEMALE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; UNITED KINGDOM; VERY ELDERLY; ADOLESCENT; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DIAGNOSIS; GENETICS; HEALTH SURVEY; INCIDENCE; ONSET AGE; PROCEDURES; STANDARDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DETECTION OF CANCER; GREAT BRITAIN; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MIDDLE AGED; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84925846708     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12778     Document Type: Article

References (29)

1. Lynch HT, De La Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348: 919-32.
2. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000; 118: 829-34.
3. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50: 113-30.
4. Cairns SR, Scholefield JH, Steele RJ et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010; 59: 666-89.
5. Vasen HF, Mecklin JP, Watson P et al. Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. The International Collaborative Group on HNPCC. Dis Colon Rectum 1993; 36: 1-4.
6. Mecklin JP, Jarvinen HJ, Aukee S, Elomaa I, Karjalainen K. Screening for colorectal carcinoma in cancer family syndrome kindreds. Scand J Gastroenterol 1987; 22: 449-53.
7. Love RR, Morrissey JF. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Arch Intern Med 1984; 144: 2209-11.
8. De Jong AE, Hendriks YM, Kleibeuker JH et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006; 130: 665-71.
9. Vasen HF, Den Hartog Jager FC, Menko FH, Nagengast FM. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am J Med 1989; 86: 278-81.
10. De Vos Tot Nederveen Cappel WH, Nagengast FM, Griffioen G et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 2002; 45: 1588-94.
11. Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995; 345: 1183-4.
12. Renkonen-Sinisalo L, Aarnio M, Mecklin JP, Jarvinen HJ. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev 2000; 24: 137-42.
13. Dunlop MG. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002; 51(Suppl 5): V21-7.
14. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995; 108: 1405-11.
15. Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2004; 22: 39-44.
16. De Leon MP, Pedroni M, Benatti P et al. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis. Gut 1999; 45: 32-8.
17. Jass JR. Screening for hereditary bowel cancer in New Zealand. Gut 1994; 35: 1328.
18. Mecklin JP, Jarvinen HJ. Surveillance in Lynch syndrome. Fam Cancer 2005; 4: 267-71.
19. Ponz De Leon M, Benatti P, Di Gregorio C et al. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 2004; 90: 882-7.
20. Stoffel EM, Mercado RC, Kohlmann W et al. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol 2010; 105: 1851-60.
21. Bleiker EM, Menko FH, Taal BG et al. Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 2005; 128: 280-7.
22. Pylvanainen K, Kairaluoma M, Mecklin JP. Compliance and Satisfaction with Long-Term Surveillance in Finnish HNPCC Families. Fam Cancer 2006; 5: 175-8.
23. http://info.cancerresearchuk.org/cancerstats/types/bowel/Bowel. Cancer Research UK. (accessed 1 November 2011).
24. Dove-Edwin I, Sasieni P, Adams J, Thomas HJ. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 2005; 331: 1047.
25. Plaschke J, Engel C, Kruger S et al. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 2004; 22: 4486-94.
26. Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81: 214-8.
27. Barrow E, Alduaij W, Robinson L et al. Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 2008; 74: 233-42.
28. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64: 430-3.
29. Lin KM, Shashidharan M, Thorson AG et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1998; 2: 67-71.